Metraipolis › archive › dc_7efd8a3d9907

Pharmacokinetics, distribution, metabolism, excretion and safety characterization of ZJCK-6-72: novel DYRK1A inhibitor with optimized brain exposure for… — Europe PMC PMID:42147337

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42147337
DOI: 10.3389/fphar.2026.1792258
License (as archived): solo-consultazione
Archived: 2026-11-02T22:40:52.275Z
SHA-256 of the archived text: 0cfdc110f2859709695ff1dbf6ca92140c5239f23f36f12069c5d5d8ef0af2d3
Stable URL of this page: https://metraipolis.com/documento/dc_7efd8a3d9907

How to cite

Pharmacokinetics, distribution, metabolism, excretion and safety characterization of ZJCK-6-72: novel DYRK1A inhibitor with optimized brain exposure for… — Europe PMC PMID:42147337 — Europe PMC (en), https://europepmc.org/article/MED/42147337 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7efd8a3d9907 (Metraipolis archive dc_7efd8a3d9907, sha256 0cfdc110f2859709695ff1dbf6ca92140c5239f23f36f12069c5d5d8ef0af2d3)

BibTeX

@misc{dc7efd8a3d9907,
  title = {Pharmacokinetics, distribution, metabolism, excretion and safety characterization of ZJCK-6-72: novel DYRK1A inhibitor with optimized brain exposure for… — Europe PMC PMID:42147337},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42147337},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7efd8a3d9907; sha256 0cfdc110f2859709695ff1dbf6ca92140c5239f23f36f12069c5d5d8ef0af2d3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42147337. Agents can read the archived copy with the MCP tool read_document.